Sun Pharmaceutical Industries: Plans Meetings With Analysts and Investors On September 10, 16, and 17

 03 Sep 2026 04:22 PM

Sun Pharmaceutical Industries: Plans Meetings With Analysts and Investors On September 10, 16, and 17

Sun Pharma: Secures 2-year Us Tariff Relief In Mfn Drug-pricing Deal

 02 Sep 2026 09:14 AM

Sun Pharma: Secures 2-year Us Tariff Relief In Mfn Drug-pricing Deal

Sun Pharma: Bernstein on Sun Pharma Maintains Outperform with Target Price of ₹2,235 as the MFN agreement protects and expands its US$1.2–1.3bn innovative-medicines franchise, potentially improving patient access and biologic adoption through lower Medicaid pricing and reduced authorization barriers.

 02 Sep 2026 08:43 AM

Sun Pharma: Bernstein on Sun Pharma Maintains Outperform with Target Price of ₹2,235 as the MFN agreement protects and expands its US$1.2–1.3bn innovative-medicines franchise, potentially improving patient access and biologic adoption through lower Medicaid pricing and reduced authorization barriers.

Sun Pharma: HSBC on Sun Pharma Maintains Buy with Target Price of ₹2,120 as the MFN deal removes the tariff overhang for two years, with limited estimated FY29 EPS impact and further clarity awaited.

 02 Sep 2026 08:43 AM

Sun Pharma: HSBC on Sun Pharma Maintains Buy with Target Price of ₹2,120 as the MFN deal removes the tariff overhang for two years, with limited estimated FY29 EPS impact and further clarity awaited.

Sun Pharma: Supports White House's Medicine Access Push With Most Favored Nation Pricing For US Medicaid, Deferring Section 232 Tariffs And Acquiring Organon For $11.75 Billion To Boost US Market Growth.

 01 Sep 2026 07:35 AM

Sun Pharma: Supports White House's Medicine Access Push With Most Favored Nation Pricing For US Medicaid, Deferring Section 232 Tariffs And Acquiring Organon For $11.75 Billion To Boost US Market Growth.

India Govt Seeks Joint Ventures With Japanese Companies In Pharma And Shipbuilding, Says Goyal

 27 Aug 2026 11:09 AM

India Govt Seeks Joint Ventures With Japanese Companies In Pharma And Shipbuilding, Says Goyal

Sun Pharma: Gets Positive Ruling From Appellate Court In Lipitor Antitrust Case, Upholding Summary Judgment For Company And Its Subsidiaries.

 17 Aug 2026 09:04 AM

Sun Pharma: Gets Positive Ruling From Appellate Court In Lipitor Antitrust Case, Upholding Summary Judgment For Company And Its Subsidiaries.

Sun Pharma: Co Faces Delhi High Court Challenge For Semaglutide Tablet Launch, Court Orders Approval Before Selling After Novo Nordisk's Patent Infringement Claim. - Newspaper

 12 Aug 2026 09:02 AM

Sun Pharma: Co Faces Delhi High Court Challenge For Semaglutide Tablet Launch, Court Orders Approval Before Selling After Novo Nordisk's Patent Infringement Claim. - Newspaper

Sun Pharma: Anticipates Pricing Challenges In Upcoming Quarters

 03 Aug 2026 12:08 PM

Sun Pharma: Anticipates Pricing Challenges In Upcoming Quarters

SUN PHARMACEUTICAL INDUSTRIES: Q1 CONS NET PROFIT 29B RUPEES VS 23B (YOY); EST 30.5B

 31 Jul 2026 02:29 PM

SUN PHARMACEUTICAL INDUSTRIES: Q1 CONS NET PROFIT 29B RUPEES VS 23B (YOY); EST 30.5B

SUN PHARMACEUTICAL INDUSTRIES: Q1 REVENUE 153B RUPEES VS 138B (YOY); EST 156.25B

 31 Jul 2026 02:30 PM

SUN PHARMACEUTICAL INDUSTRIES: Q1 REVENUE 153B RUPEES VS 138B (YOY); EST 156.25B

SUN PHARMACEUTICAL INDUSTRIES: Q1 EBITDA 44.2B RUPEES VS 43B (YOY); EST 42.55B || Q1 EBITDA MARGIN 28.9% VS 31.06% (YOY); EST 27.2%

 31 Jul 2026 02:30 PM

SUN PHARMACEUTICAL INDUSTRIES: Q1 EBITDA 44.2B RUPEES VS 43B (YOY); EST 42.55B || Q1 EBITDA MARGIN 28.9% VS 31.06% (YOY); EST 27.2%

SUN PHARMACEUTICAL INDUSTRIES: Q1 U.S. SALES AT USD 427M VS 473M (YOY), DOWN 10%

 31 Jul 2026 02:33 PM

SUN PHARMACEUTICAL INDUSTRIES: Q1 U.S. SALES AT USD 427M VS 473M (YOY), DOWN 10%

Sun Pharmaceutical Industries: Gets Approval From Anvisa To Produce And Sell Semaglutide In Brazil

 29 Jul 2026 10:06 PM

Sun Pharmaceutical Industries: Gets Approval From Anvisa To Produce And Sell Semaglutide In Brazil

Sun Pharmaceutical Industries: Partner Philogen Re-Submits NIDLEGY™ Application To EMA For Advanced Melanoma Treatment.

 27 Jul 2026 04:03 PM

Sun Pharmaceutical Industries: Partner Philogen Re-Submits NIDLEGY™ Application To EMA For Advanced Melanoma Treatment.

Sun Pharma: Gets Green Light To Produce And Sell Generic Semaglutide In South Africa; Launching Soon As Ready-To-Use Multi-Dose Injectable Pen.

 15 Jul 2026 08:56 AM

Sun Pharma: Gets Green Light To Produce And Sell Generic Semaglutide In South Africa; Launching Soon As Ready-To-Use Multi-Dose Injectable Pen.

Sun Pharmaceutical Industries: Will Hold Q1 Earnings Call On July 31 At 6:30 PM.

 14 Jul 2026 08:31 PM

Sun Pharmaceutical Industries: Will Hold Q1 Earnings Call On July 31 At 6:30 PM.

Sun Pharmaceutical Industries: Plans To Review Q1 Results On July 31.

 10 Jul 2026 03:55 PM

Sun Pharmaceutical Industries: Plans To Review Q1 Results On July 31.

Sun Pharma: Co To Buy 100% Of Innovcare Lifesciences || Deal Value 2.71b Rupees

 20 Jun 2026 05:32 PM

Sun Pharma: Co To Buy 100% Of Innovcare Lifesciences || Deal Value 2.71b Rupees

Sun Pharmaceutical Industries: Citi maintains a Buy on Sun Pharmaceutical Industries with a Target Price of ₹2180, citing strong ASCO 2026 data reinforcing UNLOXCYT’s competitive positioning in laCSCC, improved confidence on efficacy and tolerability, and supporting expectations of $400m+ peak sales by FY30.

 27 May 2026 08:56 AM

Sun Pharmaceutical Industries: Citi maintains a Buy on Sun Pharmaceutical Industries with a Target Price of ₹2180, citing strong ASCO 2026 data reinforcing UNLOXCYT’s competitive positioning in laCSCC, improved confidence on efficacy and tolerability, and supporting expectations of $400m+ peak sales by FY30.